Atlas Trials

Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer

Clinical trial NCT01827943 · COMPLETED

Trial details

NCT number
NCT01827943
Sponsor
Institut Bergonié
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed Bladder Cancer
Start date
2009-06-01
Primary completion
2014-12-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.